Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-041528

Director sold 11,000 shares at an average $257.48 ($2,832,335)

  • Director acquired 11,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Levy Richard S Director 2024-04-01 Option exercise 10b5-1 +5,000 $7.36 $36,800 15,298 D
Levy Richard S Director 2024-04-01 Option exercise 10b5-1 +6,000 $111.06 $666,360 21,298 D
Levy Richard S Director 2024-04-01 Sale 10b5-1 −4,387 $255.90 $1,122,629 16,911 D
Levy Richard S Director 2024-04-01 Sale 10b5-1 −3,900 $256.88 $1,001,836 13,011 D
Levy Richard S Director 2024-04-01 Sale 10b5-1 −1,600 $257.93 $412,696 11,411 D
Levy Richard S Director 2024-04-01 Sale 10b5-1 −100 $259.07 $25,907 11,311 D
Levy Richard S Director 2024-04-01 Sale 10b5-1 −713 $265.28 $189,145 10,598 D
Levy Richard S Director 2024-04-01 Sale 10b5-1 −300 $267.07 $80,122 10,298 D
Derivatives
Levy Richard S Director 2024-04-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 15,000 D
Levy Richard S Director 2024-04-01 Option exercise · Stock Option (Right to Buy) 10b5-1 −6,000 0 D
Open-market sales · 11,000 sh · avg $257.48 · $2,832,335
Loading xslF345X05/ownership.xml…